Here's a little information about a very common pathogen in human diseases Streptococcus pyogenes. This presentation consists of the history of the organism, its introduction, its morphology, the cell antigens and proteins, the diseases caused by this organism its diagnosis and treatment. I hope it is helpful for the people studying medical microbiology.
Here's a little information about a very common pathogen in human diseases Streptococcus pyogenes. This presentation consists of the history of the organism, its introduction, its morphology, the cell antigens and proteins, the diseases caused by this organism its diagnosis and treatment. I hope it is helpful for the people studying medical microbiology.
Babesiosis, caused by infection with intra erythrocytic parasites of the genus Babesia, is one of the most common infections of free living animals worldwide and is gaining increasing interest as an emerging zoonosis in humans. this is a detailed study on this ......considering all the facts such as definition , management, parthenogenesis, diagnosis, treatment, prevention , etc
please comment
thank u
Genus Yersinia&Pasteurella.pptx these are gram negatives non motile bacteriajaphetPeter1
Plague is caused by the bacteria Yersinia pestis, a zoonotic bacteria usually found in small mammals and their fleas.
People infected with Y. pestis often develop symptoms after an incubation period of one to seven days.
There are two main clinical forms of plague infection: bubonic and pneumonic. Bubonic plague is the most common form and is characterized by painful swollen lymph nodes or 'buboes'.
Plague is transmitted between animals and humans by the bite of infected fleas, direct contact with infected tissues, and inhalation of infected respiratory droplets.
Plague can be a very severe disease in people, with a case-fatality ratio of 30% to 60% for the bubonic type, and is always fatal for the pneumonic kind when left untreated.
Antibiotic treatment is effective against plague bacteria, so early diagnosis and early treatment can save lives.
Currently, the three most endemic countries are the Democratic Republic of the Congo, Madagascar, and Peru.
Y. pestis survives and produces F1 and V antigens within blood cells such as monocytes, but not in neutrophils.
Natural or induced Immunity is achieved by the production of specific antibodies against F1 and V antigens
Antibodies against F1 and V induce phagocytosis by neutrophils
Y.pestis causes plague ( a zoonotic diseases which is transmitted fron rats and rodents to humans by infected fleas)
Fleas-blood sucking wingless insect of the order Siphonaptera
Occasionally the infection occurs by inhaling the organism in the airborne droplets or
By handling the infected rodents or domestic animals (e.g cats and dogs) that harbour infected fleas
Bubonic plague
Flea (bite) to humans
Pneumonic plague
Human to human after inhalation and>lungs though blood stream
Septicaemic plague
Plague-Zoonotic disease
Spread from domestic rats to man by bite of rat flea
Plague-greatest killer in history of mankind
Severe epidemics
In India-out break in 1994 (Maharashtra, Gujarat, UP, MP, Karnataka)
In 2002-outbreak in Shimla
Scattered natural foci still exist:kolar,Bead-Lathur belt in Maharashtra, Shimla and Uttaranchal
Self limiting gastroenteritis in young children
Mesenteric adenitis and inflammatory terminal ileitis in older children
Systemic disease seem in aduld:bacteremia,meningitis arthlgia,erythema nodosum
Pathogen of rodents, particularly guinea pigs
Septicemia with mesenteric lymphadenitis similar to appendicitis
Motile at 22 degree centigrade
Pasteurella species are spherical, ovoid or rod-shaped cells 0.3-1.0µm in diameter and 1.0-2.0µm in length
Cells are Gram negative, and occur singly, or in pairs or short chains
Bipolar staining may be seen
Capsules may be present
All species are non-motile
Facultative anaerobic
Microscopy
Gram-negative coccobacilli measuring 1 to 2 μm in length.
Many pathogenic isolates are encapsulated
Cultural characteristics
Primary isolation media
Blood agar incubated in 5-10% CO2 at 35-37°C for 16–48hr ,Colonies are grey and viscous but rough irregular colonies occur
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
3. Tribe Yersinieae genus
Yersinia three well-
established human
pathogens
Yersinia pestis: rodent-
borne zoonotic disease –
plague
Yersinia
pseudotuberculosis and
Y.Enterocolitica—
yersiniosis, a self-limiting
gastrointestinal illness
4. Yersinia pestis
◦ 1894 - Yersinia pestis isolated for the first time
- Alexandre Yersin in in Hong Kong
◦ Agent of plague - systemic zoonosis,
transmitted from rodents by arthropod
vector (the rat flea)
◦ Gram-negative oval coccobacillus,
bipolar staining and pleomorphism in
older cultures (enhanced with 3% NaCl)
◦ Non-motile and capsulated
5. Epidemiology of Plague - Pandemics
Biotypes Nitrate
reduction
Glycerol
fermentation
Pandemics associated
Medievalis - + First pandemic Justinian,AD541
Antiqua + + Second pandemic Black death,
Europe(1347-52)
Orientalis + - Third pandemic (1894-1918)
Hong Kong, China, India
6. Timeline of
plague in India
Four potential endemic foci
1. region near Kolar, Karnataka
2. Beed-Latur belt in Maharashtra
3. Rohru in Himachal Pradesh
4. Dangud village, Uttaranchal
7. Current situation in the world
◦ Over five years (2004 to 2009), a total of 12,503 cases were reported
(with 843 deaths) worldwide, mainly confined to 16 countries of
Africa, Asia and America
◦ Africa accounts for highest number of cases (97%) worldwide.
8. Epidemiological
factors
◦ Reservoir: Wild rodents, field mice &
bandicoot
◦ Source of infection
- infected wild rodents,
-rat fleas
-cases of pneumonic plague
◦ Vector: Rat flea
- Xenopsylla cheopis - most efficient, North
India
- Xenopsylla astia - less efficient, South India
- Xenopsylla brasiliensis
9.
10. Plague cycles: two natural cycles:
1. Domestic cycle: between humans, rat
fleas and rodents
2. Wild or sylvatic cycle: occurs in nature
among wild rodents, independent of human
beings
11. Mode of
transmission
- Bite of an infected rat flea (most common)
- Direct contact with tissues of infected
animal (rodents)
- Droplet inhalation (man to man) -
pneumonic plague
- Bite of an infected human flea (Pulex
irritans)
12. Blocked flea
Partially blocked
flea- more
dangerous –upto
4 year survival
transmission of
infection
while making
efforts to suck, it
regurgitates the
blood mixed
bacteria into the
bite
Bacilli multiply
enormously in the
gut of flea and
may block the
proventriculus
13. Contamination of bite wound with feces of infected fleas
Extrinsic incubation period – two weeks for Xenopsylla cheopis
Cheopis index - Average number of X.cheopis per rat is most
significant flea index
Cheopis index >1 outbreak likely
-Seasonality: North India - September to May, South India -
throughout the year
14. Virulence factors of Y. pestis
Yersiniae Virulence antigens
Common to all Yersinia Lipopolysaccharide- endotoxin activity
Pigmentation-
absorbs hemin,brown colonies,biofilm
Low calcium response plasmid codes for type III secretion system
Siderophore- iron acquisition, reduces ROS
Y.pestis specific Fraction 1 (F1) antigen- heat labile capsular protein, inhibits phagocytosis,
antigenic
Phospholipase D/murine toxin- survival in midgut of flea
Surface proteases– activate plasminogen, degrade complement, adhere to
laminin, dissemination of infection
15. Essentials of Medical Microbiology
Yersiniae Virulence antigens
Y. pestis & Y.pseudotuberculosis pH 6 antigen
Y.enterocolitica and
Y.pseudotuberculosis
Inv protein
Ail protein
Yersinia adhesin A (YadA)
Y.enterocolitica specific Myf antigen
Heat stable toxin (ST toxin)
Y. pseudotuberculosis specific Super antigen mitogen
17. Bubonic plague
Most common type, transmitted by the bite of an infected rat flea
Bacilli pass through the local lymphatics regional lymph nodes multiply
Incubation period: 2–7 days
Sudden onset, fever, malaise, headache & painful lymphadenitis
Buboes: Regional lymph nodes - tense, tender swellings “buboes”
Common site - inguinal
Other sites - crural, axillary, cervical, or submaxillary
Cannot spread from person to person
Without treatment, dissemination occurs leading to pneumonia (secondary) and meningitis
18. Pneumonic plague
Spread: Inhalation of bacilli in droplets
expelled from another person or an animal
with plague pneumonia
Incubation period: 1–3 days
Manifestation: Sudden onset fever,
headache and respiratory symptoms pain
Rare (<1%) but highly infectious and highly
fatal
Agent of bioterrorism
19. Septicemic plague
◦ Secondary septicemic plague is more common
than Primary
◦ From spread of bubonic or pneumonic plague
◦ Incubation period:2–7 days
◦ Hemorrhages in the skin and mucosa gangrene
of affected site- black death
20. Lab diagnosis
◦ Specimen Collection
- Bubonic plague—pus or fluid
aspirated from buboes
- Pneumonic plague—sputum
and blood
- Septicemic plague—blood and
splenic aspirate (post mortem)
◦ Transport medium - Cary–Blair
medium
21. Direct microscopy
◦ Gram staining
Gram negative oval coccobacilli with
rounded ends and convex sides surrounded
by capsule
◦ Wayson stain or methylene blue stain
bipolar or safety pin appearance- 2 ends
darkly stained, central clear area
22. Culture
◦ Y. pestis is aerobic and facultatively anaerobic
◦ Optimum temperature - 27°C but the capsule develops best at 37°C
◦ Not fastidious
◦ Blood agar: Non-hemolytic and dark brown pigmented colonies
(absorption of the hemin)
◦ MacConkey agar: Lactose non-fermenting
23. • Nutrient broth: Granular turbidity surface
pellicles
• Nutrient broth with oil or ghee floated on top -
stalactites-like growth
• Yersinia-specific CIN agar (cefsulodin, irgasan,
novobiocin): selective medium, useful for culture
of specimens containing normal flora, e.g.
sputum.
24. Culture smear
and motility
testing
◦ Gram stain – pleomorphic
coccid, coccobacillary, bacillary,
filamentous and giant forms
◦ Y.pestis - nonmotile both at 25°C
and 37°C
25. Biochemical
reactions
◦ Sugar fermentation:
- Ferments glucose, mannitol and maltose
with the production of acid but no gas.
- Lactose and sucrose are not fermented
◦ Catalase positive, oxidase negative
◦ Indole, urease and citrate tests are
negative
◦ MR positive, but VP test is negative
◦ Biotyping is done based on glycerol
fermentation and nitrate reduction
26. F1 Antigen Detection
From bubo aspirate or sputum by direct immunofluorescence test, ELISA or immunochromatographic
test (ICT)
Antibodies to F1 Antigen Detection
-By ELISA, passive agglutination or CFT
-Limited diagnostic value as they appear late
-Useful epidemiological markers
Molecular Methods:
-PCR - gene coding F1 antigen, pesticingene, and the plasminogen activator gene
Animal Inoculation - Guinea pigs or white rats
27. Treatment
◦ Gentamicin - DOC
◦ Alternatives:
- Streptomycin - 10 days
- Levofloxacin - for treatment and
postexposure prophylaxis
- Doxycycline and Chloramphenicol
- β-lactams and Macrolides - not
recommended as the response is poor
28. Prophylaxis
◦ Control of cases by early diagnosis, isolation
and treatment of cases
◦ Control of fleas by use of effective
insecticides - DDT or BHC (beta-
hexachloro-cyclohexane)
◦ Control of rodents
◦ Chemoprophylaxis - contacts of
pneumonic plague
- Doxycycline (100 mg bid)
- Tetracycline (500 mg qid)
29. Vaccines
◦ Only for prevention of an anticipated outbreak and not for general use
◦ Formalin killed vaccine (Sokhey’s modification of original Haffkine
vaccine):
- Subcutaneous, two doses 4 weeks apart booster after 6 months
- Protection is short-lasting (<6 months)
- Not protective against pneumonic plague and has considerable side effects
30. Live attenuated vaccine based on strain EV76
-still used in countries of the former Soviet Union
-Has significant side effects
Subunit recombinant F1 (rF1) vaccine - under trial
31. YERSINOSIS
Zoonotic infection - by enteropathogenic Yersinia
species – Y.enterocolitica or Y. pseudotuberculosis
Usual hosts - Pigs & other wild/domestic animals
Human infection - consumption of contaminated
food (raw pork, milk)
Most common in childhood and in colder climates
Presentation - abdominal pain and sometimes diarrhea
32. Geographical Distribution
Y. Enterocolitica - found worldwide, most commonly in Northern Europe and
America
Y. Pseudotuberculosis – rare, Finland
Serogrouping
Y. Enterocolitica – six biotypes and 60 serotypes
Commonest infections with serogroups O:3 and O:9
Y. pseudotuberculosis - six serotypes (1 to 6)
33. Virulence factors- common to both species
Invasin (Inv) protein: Binds to β-1 integrins on M cells of GI mucosa
which helps in invasion
Ail protein (attachment and invasion locus): It helps in attachment,
invasion and inactivates complements
Yersinia adhesin A (Yad A): Helps in invasion & inactivates
complements
34. All Yersiniae-LPS, pigments, siderophores and low calcium response plasmid
Y. enterocolitica specific virulence factors:
- Myf antigen - fimbrial antigen, helps in adhesion
- Heat-stable toxin: Similar to that of E. coli, produced only at temperature <30°C
- pH6 antigen: Fimbrial surface protein, helps in adhesion
Y. pseudotuberculosis specific virulence factors:
- Super antigen—binds to T cells non-specifically leading to massive cytokine release
35. Clinical features
◦ Y. Enterocolitica more common than Y. pseudotuberculosis
◦ Self-limited gastroenteritis (diarrhea with or without blood) -
younger children
◦ Intestinal complications - older children, characterized by
terminal ileitis and mesenteric adenitis
- Patients present with acute pain abdomen, may mimic
pseudoappendicitis
◦ Septicemia: typically in adults - fever and leukocytosis
- with coexisting diabetes mellitus, liver disease and iron overload
36. Post infective phenomena
With Y. Enterocolitica
Autoimmune activity - deposition of bacterial non-viable components in joints and other sites
- Reactive arthritis (association with HLA-B 27)
- Erythema nodosum
- Graves’ disease - Y. enterocolitica has antigen similar to TSH binding site
Super antigen: Some strains of Y. Pseudotuberculosis - mitogen scarlet-like fever, Izumi-
fever and idiopathic acute systemic vasculitis of childhood (Kawasaki’s disease)
37. Lab diagnosis
Culture isolation
◦ From blood: BHI broth
◦ From lymph nodes aspirate: blood agar,
nutrient agar and MacConkey agar
- Blood agar: granular translucent colonies
with a beaten copper surface, non-hemolytic
colonies
- MacConkey agar: Growth of Y.
Pseudotuberculosis is poor. Y. enterocolitica grows
well and produces lactose non-fermenting
pale colonies
38. For isolation from feces, food or soil: Selective media
-Deoxycholate citrate agar
-MacConkey agar
-Yersinia CIN agar (Cefsulodin-irgasan-novobiocin): Dark red bull’s
eye colonies
Incubation: at 25°C and 37°C - differentiate from other pathogens which
grow only at 37°C
Cold enrichment - phosphate-buffered saline at 4°C for 3 weeks
39. Biochemical
Tests
Y. enterocolitica and Y. Pseudotuberculosis
can be differentiated from Y. pestis:
- Differential motility: motile at 22°C
(but not at 37°C)
- Cold enrichment: Growth improves
on refrigeration (4°C)
- Urease positive
40. Y. enterocolitica v/s Y. Pseudotuberculosis :
-Sugar fermentation - Sucrose, cellobiose and sorbitol are fermented only by
Y.Enterocolitica
-Rhamnose, salicin and melibiose are fermented only by Y. Pseudotuberculosis
- Ornithine decarboxylase-positive only for Y. Enterocolitica
-VP test is positive only for Y. Enterocolitica
Serology – Antibodies detected by agglutination or ELISA using serotype
specific O-antigen types
41. Treatment
◦ Mostly diarrhea is self-limiting.
◦ Treatment is required only for systemic
infections – septicemia
◦ Fluoroquinolone (Ciprofloxacin) or third-
generation Cephalosporins (Cefotaxime)
◦ Y. enterocolitica strains nearly always produce β-
lactamases but not Y. pseudotuberculosis strains
42. Francisella
tularensis
◦ Tularemia – plague like disease of rodents & other
small animals
◦ Source- contaminated environment, insects, other
animals
◦ Transmission-zoonotic
-interaction with biting/ blood sucking
insects(ticks/tabanid flies)
-contact with wild/ domestic animals
-contaminated food/water
-Inhalation of infective aerosols
43. Clinical features
o Ulceroglandular tularemia
-most common form
-Ulcer + regional lymohadenopathy
o Pulmonary tularemia-atypical pneumonia
o Oropharyngeal tularemia
-ingestion of contaminated undercooked meat
-membranous pharyngitis+ cervical lymohadenopathy
-Lemming fever
o Oculoglandular tularemia
-purulent conjunctivitis+pre auricular lymphadenopathy
o Typhoid like illness
o Agent of bioterrorism
44. Lab diagnosis
Culture -Highly fastidious,special media
-BCG (Blood cysteine glucose agar)
-CHAB(cysteine heart agar
supplemented with 9% sheep blood)
Specimens
-Ulcer scrapings
-LN biopsy
-Gastric washings
-Sputum
-Blood
47. Pasteurella
◦ Respiratory tract of animals, commensal in
human respiratory tract
◦ Most common- Pasteurella multocida
◦ Following animal bite- red, swollen, painful,
regional lymphadenopathy, fever
Meningitis
Appendicitis
Chronic respiratory infections
48. Lab diagnosis and
treatment
◦ Direct microscopy
Non motile Gram negative cocco-bacilli with bipolar
staining
◦ Culture
Aerobes and facultative anaerobes
Grow on NA at 370
C
Oxidase (+)
Indole (+)
Fail to grow on MA
TREATMENT
Penicillin-G / Amoxycillin clavulanate DOC